From: 13/07/2017 to: 18/07/2017 ESMO-ESO Course on Medical Oncology for Medical Students, Valencia, Spain                                        From: 15/07/2017 to: 15/07/2017 Breast Cancer in Young Women: Joint DFCI-ESO Symposium, Boston, US                                        From: 28/08/2017 to: 08/09/2017 ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students, Antwerp, Belgium                                        From: 06/10/2017 to: 07/10/2017 Eastern Europe and Balkan Region Refresher Course on Breast Cancer, Krakow, Poland                                        From: 18/10/2017 to: 20/10/2017 4th Masterclass in Clinical Oncology, Tbilisi, Georgia                                        From: 18/10/2017 to: 18/10/2017 ESO Breast Cancer Observatory, Tehran, Iran                                        From: 27/10/2017 to: 28/10/2017 9th Clinical Oncology Update - Onkologia 2017, Krakow, Poland                                        From: 02/11/2017 to: 04/11/2017 ESO-ESMO Advanced Breast Cancer Fourth International Consensus Conference (ABC4), Lisbon, Portugal                                        From: 02/12/2017 to: 04/12/2017 ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers, Milan, Italy                                        From: 15/12/2017 to: 18/12/2017 6th Arab and Southern European Countries Masterclass in Clinical Oncology, Limassol, Cyprus                                        From: 24/03/2018 to: 29/03/2018 17th ESO-ESMO Masterclass in Clinical Oncology, Nauen OT Groß Behnitz (Berlin area), Germany                                        From: 18/04/2018 to: 22/04/2018 4th ESO-ESMO Latin-American Masterclass in Clinical Oncology, Mexico City, Mexico                                        From: 6/10/2018 to: 8/10/2018 4th ESO-ESMO Breast Cancer in Young Women International Conference, Lugano, Switzerland

 Fondazione IRCCS Istituto Nazionale dei Tumori                                                   
 Milan, Italy



Person responsible for CTC programme: Paolo  G. Casali


Hospital overview:

Fondazione IRCCS Istituto Nazionale dei Tumori (INT) is one of the main national and international referral centers for the treatment and study of cancer and it is the largest comprehensive cancer centre in Italy. Since its establishment (1928), it has aimed to provide the highest standards of cancer care and to pursue pre-clinical and clinical research in such a way as to swiftly translate innovation into better prevention, diagnosis, therapy and rehabilitation for Italian cancer patients.

Istituto Nazionale Tumori strongly pursues the objective of multidisciplinary care, working through disease-based multidisciplinary groups. This provides the most appropriate diagnostic and therapeutic options, based on state-of-the-art scientific evidence, within a framework of integrated knowledge, resource management, and research support.

Istituto Nazionale Tumori has a long-standing record on rare cancers, serving as one of the Italian reference centers for several rare cancers, including childhood cancers, sarcomas, head & neck cancers, peritoneal and pleural mesothelioma and thymoma, neuroendocrine tumors, male genital tumors, rare female genital cancers, rare digestive cancers, in addition to haematological cancers. It coordinates the Italian Rare Cancer Network, i.e., a healthcare national network exploiting telemedicine for distant rare adult solid cancer case-sharing between reference centers and medical oncology facilities throughout Italy. It is the coordinating Institution of the Joint Action on Rare Cancers of the European Union and serves as the domain leader for sarcomas and for head & neck rare cancers within the EU "EUropean reference network on Rare Adult CANcers" (EURACAN).


Language requirements:
Local language is Italian. The second language spoken at Istituto Nazionale Tumori is English. For visiting residency status, if Italian is not spoken, intermediate-level in English is required.


CTC programmes offered:

RARE ADULT SOLID CANCERS

1. Rare thoracic cancers
 
Programme mentor:

M. Garassino

Duration:3 - 6 months

Type:Visiting Residency and Visiting Observership

  
  
2. Rare female genital tumors
 

Programme mentor:

D. Lorusso

 

Duration:
3 - 6 months

Type:
Visiting Residency and Visiting Observership

  
  
3. Rare urological and male genital tumors
 
Programme mentor:N. Nicolai

Duration:3 - 6 months

Type:Visiting Residency and Visiting Observership

  
  
4. Neuroendocrine tumors and biliary tumors
 
Programme mentor:F. De Braud

Duration:
3 - 6 months

Type:Visiting Residency and Visiting Observership

  
  
5. Adult soft tissue sarcomas and gastrointestinal stromal tumors
 
Programme mentor:
P.G. Casali

Duration:
3 - 6 months

Type:Visiting Residency and Visiting Observership

  
  
6. Head and Neck Cancers
 
Programme mentor:
L. Licitra

Duration:3 - 6 months

Type:Visiting Residency and Visiting Observership